Heat shock protein 90 transfection reduces ischemia-reperfusion-induced myocardial dysfunction via reciprocal endothelial NO synthase serine 1177 phosphorylation and threonine 495 dephosphorylation - PubMed (original) (raw)
Heat shock protein 90 transfection reduces ischemia-reperfusion-induced myocardial dysfunction via reciprocal endothelial NO synthase serine 1177 phosphorylation and threonine 495 dephosphorylation
Christian Kupatt et al. Arterioscler Thromb Vasc Biol. 2004 Aug.
Abstract
Objectives: The interaction of the heat shock protein 90 (Hsp90) with the endothelial NO synthase (eNOS) has been shown to account for a sustained production of NO in vitro. Here, we examined whether overexpression of Hsp90 in a pig model of cardiac infarct could preserve the myocardium from the deleterious effects of ischemia-reperfusion.
Methods and results: Percutaneous liposome-based gene transfer was performed by retroinfusion of the anterior interventricular vein before left anterior descending occlusion and reperfusion. We found that recombinant Hsp90 expression in the ischemic region of the heart led to a 33% reduction in infarct size and prevented the increase in postischemic left ventricular end diastolic pressure observed in mock-transfected animals. Regional myocardial function, assessed by subendocardial segment shortening in the infarct region, was increased in Hsp90-transfected animals at baseline and after pacing. All these effects were completely abrogated by administration of the NOS inhibitor N(G)-nitro-L-arginine methyl ester. We further documented in vivo and in cultured endothelial cells that the cardioprotective effects of Hsp90 were associated to its capacity to act as an adaptor for both the kinase Akt and the phosphatase calcineurin, thereby promoting eNOS serine 1177 phosphorylation and threonine 495 dephosphorylation, respectively.
Conclusions: Hsp90 is a promising target to enhance NO formation in vivo, which may efficiently reduce myocardial reperfusion injury.
Similar articles
- VEGF165 transfection decreases postischemic NF-kappa B-dependent myocardial reperfusion injury in vivo: role of eNOS phosphorylation.
Kupatt C, Hinkel R, Vachenauer R, Horstkotte J, Raake P, Sandner T, Kreuzpointner R, Müller F, Dimmeler S, Feron O, Boekstegers P. Kupatt C, et al. FASEB J. 2003 Apr;17(6):705-7. doi: 10.1096/fj.02-0673fje. Epub 2003 Feb 5. FASEB J. 2003. PMID: 12586740 - Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT, Widegren U, Bulhak A, Salehzadeh F, Persson J, Sjöquist PO, Pernow J. Gonon AT, et al. Cardiovasc Res. 2008 Apr 1;78(1):116-22. doi: 10.1093/cvr/cvn017. Epub 2008 Jan 25. Cardiovasc Res. 2008. PMID: 18222959 - Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
Lv L, Jiang SS, Xu J, Gong JB, Cheng Y. Lv L, et al. Clin Exp Pharmacol Physiol. 2012 Jan;39(1):20-7. doi: 10.1111/j.1440-1681.2011.05628.x. Clin Exp Pharmacol Physiol. 2012. PMID: 22004361 - Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin.
Venema RC. Venema RC. Int Immunopharmacol. 2002 Dec;2(13-14):1755-62. doi: 10.1016/s1567-5769(02)00185-6. Int Immunopharmacol. 2002. PMID: 12489789 Review. - Nitric oxide and cardioprotection during ischemia-reperfusion.
Jugdutt BI. Jugdutt BI. Heart Fail Rev. 2002 Oct;7(4):391-405. doi: 10.1023/a:1020718619155. Heart Fail Rev. 2002. PMID: 12379824 Review.
Cited by
- Identification of a NF-κB cardioprotective gene program: NF-κB regulation of Hsp70.1 contributes to cardioprotection after permanent coronary occlusion.
Wilhide ME, Tranter M, Ren X, Chen J, Sartor MA, Medvedovic M, Jones WK. Wilhide ME, et al. J Mol Cell Cardiol. 2011 Jul;51(1):82-9. doi: 10.1016/j.yjmcc.2011.03.011. Epub 2011 Mar 23. J Mol Cell Cardiol. 2011. PMID: 21439970 Free PMC article. - Histone deacetylase inhibitor panobinostat induces calcineurin degradation in multiple myeloma.
Imai Y, Ohta E, Takeda S, Sunamura S, Ishibashi M, Tamura H, Wang YH, Deguchi A, Tanaka J, Maru Y, Motoji T. Imai Y, et al. JCI Insight. 2016 Apr 21;1(5):e85061. doi: 10.1172/jci.insight.85061. JCI Insight. 2016. PMID: 27699258 Free PMC article. - Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte.
Ota A, Zhang J, Ping P, Han J, Wang Y. Ota A, et al. Circ Res. 2010 Apr 30;106(8):1404-12. doi: 10.1161/CIRCRESAHA.109.213769. Epub 2010 Mar 18. Circ Res. 2010. PMID: 20299663 Free PMC article. - Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection.
Hinkel R, El-Aouni C, Olson T, Horstkotte J, Mayer S, Müller S, Willhauck M, Spitzweg C, Gildehaus FJ, Münzing W, Hannappel E, Bock-Marquette I, DiMaio JM, Hatzopoulos AK, Boekstegers P, Kupatt C. Hinkel R, et al. Circulation. 2008 Apr 29;117(17):2232-40. doi: 10.1161/CIRCULATIONAHA.107.758904. Epub 2008 Apr 21. Circulation. 2008. PMID: 18427126 Free PMC article. - Araloside C Prevents Hypoxia/Reoxygenation-Induced Endoplasmic Reticulum Stress via Increasing Heat Shock Protein 90 in H9c2 Cardiomyocytes.
Du Y, Wang M, Liu X, Zhang J, Xu X, Xu H, Sun G, Sun X. Du Y, et al. Front Pharmacol. 2018 Apr 17;9:180. doi: 10.3389/fphar.2018.00180. eCollection 2018. Front Pharmacol. 2018. PMID: 29719506 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous